Cookie Consent by FreePrivacyPolicy.com
Datalog Logo
Free data on 57M+ companies
Home > USA > Delaware State Companies > Glaxosmithkline Holdings (americas) Inc.
Company Information for

Glaxosmithkline Holdings (americas) Inc.

Delaware,
Company Registration Number
USDE3140277
Unknown

Company Overview

About Glaxosmithkline Holdings (americas) Inc.
Glaxosmithkline Holdings (americas) Inc. was founded on and has its registered office in Delaware. The organisation's status is listed as "Unknown". Glaxosmithkline Holdings (americas) Inc. is a business registered in United States of America (USA) with State of Delaware Division of Corporations
Key Data
Company Name
Glaxosmithkline Holdings (americas) Inc.
 
Legal Registered Office / Registered Agent
Delaware
 
Filing Information
Company Number USDE3140277
Delaware company number# 3140277
Date formed 
Country United States of America (USA)
Origin Country United States of America (USA)
Type 
CompanyStatus Unknown
Lastest accounts 
Account next due 
Latest return 
Return next due 
Type of accounts 
Jurisdiction State of Delaware Division of Corporations
Last Datalog update: 2017-01-24 20:29:44
Primary Source:State of Delaware Division of Corporations
Is this data useful to you?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.
Corporation Filing History
State of Delaware Division of Corporations Filing History
This is a record of the public documents (corporate filing) lodged from State of Delaware Division of Corporations where the company has filed annual returns and other statutory filing documents. Examples of documents filed include: change of registered office, accounts filing, director/officer appointments & resignations, changes in share capital, shareholder members lists etc.

Sorry we do not have the filing history available yet. We do about 500,000 updates per day so the filing history should be available soon. US

Industry Information
SIC/NAIC Codes




Licences & Regulatory approval
We could not find any licences issued to Glaxosmithkline Holdings (americas) Inc. or authorisation from an industry specific regulator to operate. These may not be required.
Share this page on Facebook
Risks
Legal Notices
No legal notices or events such as winding-up orders or proposals to strike-off have been issued
Fines / Sanctions
No fines or sanctions have been issued against Glaxosmithkline Holdings (americas) Inc.
Intangible Assets
Patents
We have not found any records of Glaxosmithkline Holdings (americas) Inc. registering or being granted any patents
Domain Names
We do not have the domain name information for Glaxosmithkline Holdings (americas) Inc.
Trademarks
We have not found any records of Glaxosmithkline Holdings (americas) Inc. registering or being granted any trademarks
Income
Government Income

Government spend with Glaxosmithkline Holdings (americas) Inc.

Government Department Income DateTransaction(s) Value Services/Products
7523: CENTERS FOR DISEASE CONTROL AND PREVENTION 2015-10 USD $-39,875 PEDIATRIC FLU VACCINE
7523: CENTERS FOR DISEASE CONTROL AND PREVENTION 2015-8 USD $-1,132 GSK VFC 2010
7001: OFFICE OF PROCUREMENT OPERATIONS 2014-11 USD $0 IGF::OT::IGF EXERCISE OPTION YR 4 FOR GSK IDIQ HSHQDC-10-D-00025
7001: OFFICE OF PROCUREMENT OPERATIONS 2014-7 USD $0 IGF::OT::IGF EXERCISE OPTION YR 4 FOR GSK IDIQ HSHQDC-10-D-00025
7001: OFFICE OF PROCUREMENT OPERATIONS 2014-6 USD $0 IGF::OT::IGF EXERCISE OPTION YR 4 FOR GSK IDIQ HSHQDC-10-D-00025
7001: OFFICE OF PROCUREMENT OPERATIONS 2014-3 USD $401,820 PROCUREMENT OF RELENZA UNDER HSHQDC-10--D-00025 GSK
9700: DEPT OF DEFENSE 2011-8 USD $22,807 VACCINE
7523: CENTERS FOR DISEASE CONTROL AND PREVENTION 2011-8 USD $45,630,910 GSK VFC 2011
9700: DEPT OF DEFENSE 2011-7 USD $0 VACCINE
7523: CENTERS FOR DISEASE CONTROL AND PREVENTION 2011-7 USD $49,974,930 GSK VFC 2011
9700: DEPT OF DEFENSE 2011-6 USD $29,425 VACCINE
7001: OFFICE OF PROCUREMENT OPERATIONS 2011-6 USD $0 EXERCISE OPTION YR 1 FOR GSK IDIQ HSHQDC-10-D-00025
7523: CENTERS FOR DISEASE CONTROL AND PREVENTION 2011-6 USD $-5,391,554 VACCINE FOR CHILDREN 2011
9700: DEPT OF DEFENSE 2011-5 USD $7,584 EVERGIX B
7523: CENTERS FOR DISEASE CONTROL AND PREVENTION 2011-5 USD $-8,387 GSK FLU 2008
7001: OFFICE OF PROCUREMENT OPERATIONS 2011-4 USD $0 NOVATION TO CHANGE NAME AND DUNS NUMBER
7523: CENTERS FOR DISEASE CONTROL AND PREVENTION 2011-4 USD $182,321,608 PEDIATRIC FLU VACCINE
7523: CENTERS FOR DISEASE CONTROL AND PREVENTION 2011-3 USD $20,000 ADULT FLU VACCINE
7523: CENTERS FOR DISEASE CONTROL AND PREVENTION 2011-2 USD $0 GSK VFC 2010
9700: DEPT OF DEFENSE 2011-1 USD $6,726 FLU SHOTS
7523: CENTERS FOR DISEASE CONTROL AND PREVENTION 2011-1 USD $68,524,882 GSK VFC 2010
9700: DEPT OF DEFENSE 2010-12 USD $4,057 TWINRIX A/B
7523: CENTERS FOR DISEASE CONTROL AND PREVENTION 2010-12 USD $4,895 GSK VFC 2010
7523: CENTERS FOR DISEASE CONTROL AND PREVENTION 2010-11 USD $87,815,370 GSK VFC 2010

How is this useful? The company sells into the government and has the following income from government. This provides an indication of the sources of their revenue. This is unlikely to be a complete picture of their income from government sources since many councils and countries do not disclose this information or do so inconsistently. For example UK central government has a £ 25,000 transaction threshold which means it is possible for significant spend to not be disclosed. Where there are multiple transactions in a month, we consolidate daily transactions to provide an aggregate value for the month - the description will apply to the first transaction and the total may not reflect all spend on the description.

Outgoings
Business Rates/Property Tax
No properties were found where Glaxosmithkline Holdings (americas) Inc. is liable for the business rates / property tax. This could be for a number of reasons.
  • The council hasnt published the data
  • We havent found or been able to process the councils data
  • The company is part of a group of companies and another company in the group is liable for business rates
  • The registered office may be a residential address which does not have a commercial designation. If the business is run from home then it won't be a commercial property and hence won't be liable for business rates.
  • Serviced offices are increasingly popular and therefore a business may not be paying business rates directly - the building owner is and this is incorporated in the office rental charge.
Government Grants / Awards
Technology Strategy Board Awards
The Technology Strategy Board has not awarded Glaxosmithkline Holdings (americas) Inc. any grants or awards. Grants from the TSB are an indicator that the company is investing in new technologies or IPR
European Union CORDIS Awards
The European Union has not awarded Glaxosmithkline Holdings (americas) Inc. any grants or awards.
Ownership
    We could not find any group structure information
    Is this data useful to you?
    If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
    Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.
    Need more information?
    We offer bespoke investigations into companies. If you need more information about this company we can gather more information as directed by you. This may, for example, be a forensic investigation such as tracing hidden assets. The engagement is on a time and materials basis. We charge GBP £ 500 per day + VAT. Contact us with a description of what you're looking for and we will assess whether we can help.